Clinical Trial Update: Study Evaluating Rimonabant Efficacy in Insulin-Treated Diabetic Patients(ARPEGGIO) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy of rimonabant in insulin-treated patients with Type 2 Diabetes Mellitus (ARPEGGIO) conducted by Sanofi. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Rimonabant (rimonabant)

Snippet

Sponsor: Sanofi | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED